Alseres Pharmaceuticals, Inc.
ALSE · OTC
6/30/2014 | 3/31/2014 | 12/31/2013 | 9/30/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $0 | $0 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $0 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $1 | $1 | $3 |
| Total Curr. Liab. | $2 | $2 | $2 | $10 |
| LT Debt | $8 | $8 | $8 | $0 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $16 |
| Total NC Liab. | $10 | $10 | $9 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $12 | $11 | $11 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$200 | -$200 | -$200 | -$200 |
| AOCI | -$0 | -$0 | $0 | -$0 |
| Other Equity | $189 | $189 | $189 | $172 |
| Total Equity | -$11 | -$11 | -$11 | -$28 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $0 | $0 | $0 |
| Net Debt | $8 | $8 | $8 | $7 |